2025
1. Absalan F, Mehdipour F, Shariat M, Talei AR, Ghaderi A. Decreased IL-10R-expressing B Cells in breast cancer patients: a potential biomarker for early cancer detection. American journal of clinical and experimental immunology. 2025;14(1):34-42.
2. Afshari F, Alaee S, Dara M, Shadi M, Chenari N, Ramezani A, et al. The synergic impact of decellularized testis scaffold and extracellular vesicles derived from human semen on spermatogonial stem cell survival and differentiation. Biomedical engineering online. 2025;24(1):94.
3. Akrami S, Kordshouli SO, Tahmasebi A, Moghadam A, Aram F, Golestan A, et al. Cytotoxic effects of five Iranian medicinal plants on pancreatic cancer cell lines and investigation of induced changes in the expression of several key genes. BMC complementary medicine and therapies. 2025;25(1):285.
4. Azhdari S, Noori S, Daneshbod K, Khalafi-Nezhad A, Hashemi SMA, Faghih Z, et al. The Prevalence of Cytogenetic Abnormalities Detected by Interphase FISH Method in Chronic Lymphocytic Leukemia. South Asian journal of cancer. 2025;14(3):601-7.
5. Bahari H, Salim Z, Kardanpour L, Kouchaki H, Shoja F, Rahnama I, et al. The Anti-Leukemic Potential of Curcumin in Chronic Myeloid Leukemia: A Systematic Review of In Vitro Studies. Food science & nutrition. 2025;13(9):e70852.
6. Darvishvand R, Asadi M, Mostafavi-Pour Z, Ramezani A, Erfani N. Generation of the augmented IL-15-secreting anti-HER2 chimeric antigen receptor (CAR)-NK cells: an encouraging immunotherapeutic tool. Molecular biology reports. 2025;53(1):3.
7. Farahani H, Darvishvand R, Khademolhosseini A, Erfani N. Unwrapping the immunological alterations in testicular germ cell tumors: From immune homeostasis to malignancy and emerging immunotherapies. Andrology. 2025;13(4):747-62.
8. Ghasemian M, Gholami MA, Fattahi MJ, Ghasemi F, Ghaderi H, Khademi B, et al. Heterogeneity in benign and malignant salivary gland tumors. Clinica chimica acta; international journal of clinical chemistry. 2025;572:120258.
9. Gholami Shahrebabak M, Kouchaki H, Gholami Shahrebabak A, Ravankhah M, Abdollahi M, Akbari M, et al. Systematic review and meta-analysis of cytomegalovirus-associated adverse outcomes and healthcare resource utilization in hospitalized patients with inflammatory bowel disease. International journal of colorectal disease. 2025;40(1):101.
10. Golestan A, Zareinejad M, Ramezani A. Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment. Biomarkers in medicine. 2025;19(6):223-38.
11. Hakimi H, Mehdipour F, Samadi M, Balouchi Anaraki S, Rasolmali R, Talei AR, et al. Granzyme B-producing B cells: a bidirectional relationship with breast cancer cells and implications for immunotherapy. American journal of clinical and experimental immunology. 2025;14(5):241-9.
12. Karandish M, Khademi B, Ziaei G, Erfani N, Moezi L, Faghih Z. Cytotoxicity and genotoxicity of orthodontic bands after aging: an in-vitro study. BMC oral health. 2025;25(1):163.
13. Khansalar S, Rostami E, Khademolhosseini A, Bayat M, Molaei V, Sarvari J, et al. Elevated Levels of Serum Interleukin-37 in Chronic Hepatitis B in Comparison with the Spontaneously Cleared and Healthy Control Groups. Viral immunology. 2025;38(8):288-93.
14. Kiani L, Momtahan M, Shiravani Z, Ghaderi A, Fattahi MJ, Moradi Alamdarloo S, et al. Role of serum IL-35 levels in patients with benign and malignant primary ovarian tumors: a case-control study. Scientific reports. 2025;15(1):12827.
15. Maghsoodi N, Nezafat N, Ramezani A. Computational design of a multi-epitope mRNA vaccine against orthopoxviruses: A path toward comprehensive poxvirus protection. Computers in biology and medicine. 2025;196(Pt A):110764.
16. Maghsoodi N, Zareinejad M, Ghaderi A, Mahmoudi Maymand E, Irajie C, Ramezani A. Anti-CD8/IL-15 (N72D)/sushi fusion protein: A promising strategy for improvement of cancer immunotherapy. Cytokine. 2025;185:156822.
17. Mahmoudi F, Takallu S, Derakhshan MA, Mirzaei E. A collagen-based bilayer nanocomposite scaffold for osteochondral tissue regeneration: integrating hydroxyapatite and cellulose nanocrystals. Journal of materials science Materials in medicine. 2025;36(1):88.
18. Mansourabadi Z, Assarehzadegan MA, Mehdipour F, Ariafar A, Faghih Z, Safari E. Neutrophil extracellular traps and reactive oxygen species: Predictors of prognosis in bladder cancer. Immunology letters. 2025;273:106991.
19. Mansourabadi Z, Moazzeni A, Akrami M, Fakhimi M, Faghih Z. Expression and Prognostic Significance of PD-1/PD-Ls in Breast Cancer Draining Lymph Nodes. Iranian journal of immunology : IJI. 2025;22(4):299-309.
20. Mohammadi Y, Kaviani E, Ahmadvand S, Dehghanian A, Ghaderi A. Prognostic significance of PD-L1 and CD45RO(+) cells in glioblastoma: The modulating role of MMR status. Journal of neuroimmunology. 2025;406:578669.
21. Moradi M, Yousefpour Marzbali M, Nazari N, Chavoshzadeh Z, Mahdaviani SA, Sadeghi-Shabestari M, et al. Measuring Dedicator of Cytokinesis 8 (DOCK8) Expression as a Flow Cytometry Biomarker for DOCK8 Deficiency Detection. Iranian journal of allergy, asthma, and immunology. 2025;24(6):799-807.
22. Naseri A, Razi S, Rezaei N. Unraveling the role of specificity protein 1 in gliomas: pathophysiology and clinical implications. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2025.
23. Panahi Meymandi AR, Ghaderi A. Adipose-Derived Stem Cells at the Crossroads of Obesity and Cancer. Stem cell reviews and reports. 2025;21(7):1901-17.
24. Saberiyan M, Ghasemi N, Jafari N, Sadeghi M, Ghaderi A, Mousavi P. Investigate of LOC101928988 Regulatory Effect on the DAPK2 Transcription in Breast Tumors. Cancer reports (Hoboken, NJ). 2025;8(2):e70115.
25. Samadi M, Daryanoosh F, Mojtahedi Z, Samsamy Pour A, Nobari H, Zarifkar AH, et al. Resistance Training and Resveratrol Supplementation Improve Cancer Cachexia and Tumor Volume in Muscle Tissue of Male Mice Bearing Colon Cancer CT26 Cell Tumors. Cell biochemistry and biophysics. 2025;83(1):619-31.
26. Shahraki PK, Kiani R, Siavash M, Bemani P. Design of a multi-epitope vaccine against Staphylococcus Aureus lukotoxin ED using in silico approaches. Scientific reports. 2025;15(1):14517.
27. Sheida F, Alipour N, Naseri A, Razi S, Manzari Tavakoli G, Moghaddam SJ, et al. Prognostic and clinicopathological value of myeloid-derived suppressor cells in lung cancer: a comprehensive systematic review and meta-analysis. Expert review of anticancer therapy. 2025:1-16.
28. Sherafat NS, Mardi A, Absalan F, Mehmandar-Oskuie A. Circular RNAs as central regulators of metabolic reprogramming and immune responses in the breast cancer microenvironment: A comprehensive review. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2025;193:118682.
29. Soltan-Alinejad P, Ramezani A, Asgari Q, Alipour H, Soltani A, Bahreini MS, et al. The recombinant protein of scorpion venom phospholipase A2 exhibits potential anti-leishmanial activity. Scientific reports. 2025;15(1):45503.
30. Tabaei S, Zareinejad M, Haghshenas MR, Shakhssalim N, Gilany K, Stensballe A, et al. Investigation of new autoantibodies in urothelial bladder cancer for biomarker discovery using immunoproteomics. Discover oncology. 2025;16(1):436.
31. Takallu S, Karimi Z, Khorshidi H, Bazargani A, Bigham-Sadegh A, Torabi Nezhad S, et al. Multifunctional Three-Layer Collagen-Based Membrane for Periodontal Guided Tissue Regeneration. ACS biomaterials science & engineering. 2025;11(12):7294-312.
32. Toghraie FS, Bayat M, Hosseini MS, Ramezani A. Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy. Cellular oncology (Dordrecht, Netherlands). 2025;48(3):559-90.
2024
1. Ahmadi N, Zareinejad M, Ameri M, Mahmoudi Maymand E, Nooreddin Faraji S, Ghaderi A, et al. Enhancing cancer immunotherapy with Anti-NKG2D/IL-15(N72D)/Sushi fusion protein: Targeting cytotoxic immune cells and boosting IL-15 efficacy. Cytokine. 2024;176:156505.
2. Ahmadvand S, Norouzi LA, Mohammadi Y, Safaei A, Khademi B, Motiee-Langroudi M, et al. Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs. BMC immunology. 2024;25(1):7.
3. Aliabadi A, Haghshenas MR, Kiani R, Koohi-Hosseinabadi O, Purkhosrow A, Pirsalami F, et al. Correction: In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning. Naunyn-Schmiedeberg's archives of pharmacology. 2024;397(4):2525.
4. Aliabadi A, Haghshenas MR, Kiani R, Koohi-Hosseinabadi O, Purkhosrow A, Pirsalami F, et al. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning. Naunyn-Schmiedeberg's archives of pharmacology. 2024;397(4):2379-88.
5. Aliabadi A, Haghshenas MR, Kiani R, Panjehshahin MR, Erfani N. Promising anticancer activity of cromolyn in colon cancer: in vitro and in vivo analysis. Journal of cancer research and clinical oncology. 2024;150(4):207.
6. Ariafar A, Kohansal E, Mousania A, Faghih Z. Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications. Iranian journal of immunology : IJI. 2024;21(2):121-31.
7. Ariafar A, Mansourabadi Z, Alipoor H, Faghih Z. Gamma-delta T Cells in Bladder Cancer Draining Lymph Nodes. Iranian journal of immunology : IJI. 2024;21(4):271-8.
8. Ariafar A, Mansourabadi Z, Rasekh S, Fakhimi M, Faghih Z. Diversity of Memory CD8(+) T Cells in Tumor-Draining Lymph Nodes from Patients with Bladder Cancer. International journal of molecular and cellular medicine. 2024;13(2):147-59.
9. Azhdari F, Faghih Z, Haghighat S, Jamalidoust M, Hosseini SY, Hashemi SMA, et al. Comparison of Epstein-Barr virus copy number in white blood cells of chronic lymphocytic leukemia patients with laboratory prognostic biomarker. BMC research notes. 2024;17(1):281.
10. Azhdari S, Noori S, Daneshbod K, Khalafi-Nezhad A, Hashemi SMA, Faghih Z, et al. The Prevalence of Cytogenetic Abnormalities Detected by Interphase FISH Method in Chronic Lymphocytic Leukemia. South Asian journal of cancer. 2025;14(3):601-7.
11. Azizi A, Mehdipour F, Samadi M, Rasolmali R, Talei AR, Ghaderi A. Atypical memory B cells increase in the peripheral blood of patients with breast cancer regardless of lymph node involvement. BMC immunology. 2024;25(1):25.
12. AziziKia H, Teymourzadeh A, Kouchaki H, Nakhostin-Ansari A, Jafari Doudaran P, Ahmadinejad I, et al. Colorectal Cancer Incidence in Iran Based on Sex, Age, and Geographical Regions: A Study of 2014-2017 and Projected Rates to 2025. Archives of Iranian medicine. 2024;27(4):174-82.
13. Babaeinia E, Ghods A, Rasolmali R, Talei AR, Mehdipour F, Ghaderi A. Interleukin (IL)-21 and IL-21 receptor expression in peripheral T and B cells of patients with breast cancer. Cellular and molecular biology (Noisy-le-Grand, France). 2024;70(4):15-22.
14. Darvishvand R, Rezaeifard S, Kiani R, Tahmasebi S, Faghih Z, Erfani N. Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer. Immunity, inflammation and disease. 2024;12(4):e1255.
15. Edalat F, Khakpour N, Heli H, Letafati A, Ramezani A, Hosseini SY, et al. Immunological mechanisms of the nucleocapsid protein in COVID-19. Scientific reports. 2024;14(1):3711.
16. Farahani H, Darvishvand R, Khademolhosseini A, Erfani N. Unwrapping the immunological alterations in testicular germ cell tumors: From immune homeostasis to malignancy and emerging immunotherapies. Andrology. 2025;13(4):747-62.
17. Farahani H, Dehghanian AR, Khademolhosseini A, Haghshenas MR, Erfani N. Frequent expression of CD45RO memory T cell marker as well as low to high expression of PD-1 and PD-L1 inhibitory molecules in seminoma and dysgerminoma. Journal of reproductive immunology. 2024;161:104184.
18. Fattahi MJ, Momtahan M, Poostkar M, Shiravani Z, Erfani N, Haghshenas MR, et al. Investigation of PD-1 gene variants in patients with endometrial cancer: A case-control study. Turkish journal of obstetrics and gynecology. 2024;21(2):57-63.
19. Fattahi MJ, Sedaghat F, Haghshenas MR, Ariafar A, Shiravani Z, Malekzadeh M, et al. Two metabolic enzymes, LDH and FASN, serum levels in Bladder cancer patients. Caspian journal of internal medicine. 2024;15(4):636-43.
20. Ghaderi H, Roshan-Zamir M, Jafarinia M, Kruger E. Oral Squamous Cell Carcinoma: Focus on Biomarkers for Screening. Journal of dentistry (Shiraz, Iran). 2024;25(1):1-16.
21. Golestan A, Tahmasebi A, Maghsoodi N, Faraji SN, Irajie C, Ramezani A. Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verification. BMC cancer. 2024;24(1):155.
22. Haghshenas MR, Khademolhosseini A, Dehghanian AR, Ghanipour F, Ghaderi H, Khansalar S, et al. Serum Interleukin-38 and Tumor-Infiltrating Lymphocytes in Primary Brain Tumors. Iranian journal of immunology : IJI. 2024;21(1):65-73.
23. Hajizade MS, Raee MJ, Faraji SN, Farvadi F, Kabiri M, Eskandari S, et al. Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study. Therapeutic delivery. 2024;15(6):399-411.
24. Heidarnejad K, Nooreddin Faraji S, Mahfoozi S, Ghasemi Z, Sadat Dashti F, Asadi M, et al. Breast cancer immunotherapy using scFv antibody-based approaches, a systematic review. Human immunology. 2024;85(5):111090.
25. Keshvari T, Melnik S, Sun L, Niazi A, Aram F, Moghadam A, et al. Efficient Expression of Functionally Active Aflibercept with Designed N-glycans. Antibodies (Basel, Switzerland). 2024;13(2).
26. Khansalar S, Faghih Z, Barani S, Kalani M, Ataollahi MR, Mohammadi Z, et al. IFN-γ, IL-17, IL-22(+) CD4(+) subset in patients with hepatitis C virus and correlation with clinical factor. American journal of clinical and experimental immunology. 2024;13(1):43-52.
27. Kordshouli SO, Tahmasebi A, Moghadam A, Ramezani A, Niazi A. A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma. PloS one. 2024;19(2):e0289561.
28. Kouchaki H, Kamyab P, Darbeheshti F, Gharezade A, Fouladseresht H, Tabrizi R. miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review. Journal of the Egyptian National Cancer Institute. 2024;36(1):16.
29. Maghsoodi N, Zareinejad M, Ghaderi A, Mahmoudi Maymand E, Irajie C, Ramezani A. Anti-CD8/IL-15 (N72D)/sushi fusion protein: A promising strategy for improvement of cancer immunotherapy. Cytokine. 2025;185:156822.
30. Mansourabadi Z, Ariafar A, Chenari N, Hakimellahi H, Vahidi Y, Faghih Z. Clinical and prognostic significance of follicular helper and regulatory T cells in bladder cancer draining lymph nodes. Scientific reports. 2024;14(1):20358.
31. Moradzadeh M, Kargar M, Erfanian S, Haghshenas MR, Hojjat-Farsangi M, Rahmanian K, et al. Effect of Crocin and Crocetin Compared to Cyclophosphamide on the Expression Level of miRNA-16-1 in a B Cell Transformed with EBV Virus Cell Line. Asian Pacific journal of cancer prevention : APJCP. 2024;25(9):3179-85.
32. Rezaei Z, Tahmasebi A, Pourabbas B. Using meta-analysis and machine learning to investigate the transcriptional response of immune cells to Leishmania infection. PLoS neglected tropical diseases. 2024;18(1):e0011892.
33. Roshan-Zamir M, Khademolhosseini A, Rajalingam K, Ghaderi A, Rajalingam R. The genomic landscape of the immune system in lung cancer: present insights and continuing investigations. Frontiers in genetics. 2024;15:1414487.
34. Sajedi Shacker M, Dehghanian AR, Kiani R, Haghshenas MR, Erfani N. High Expression of Immune Checkpoint Molecules in Different Types of Thyroid Cancer. Iranian journal of allergy, asthma, and immunology. 2024;23(5):514-25.
35. Salah M, Rezaee M, Fattahi MJ, Ghaderi A, Khademi B, Mokhtari MJ. Association of lncRNA ANRIL rs10757278 A>G Variant, Tumor Size, Grading, Tumor Site, and Tumor Stage in Oral Squamous Cell Carcinoma Patients. Reports of biochemistry & molecular biology. 2024;13(1):59-66.
36. Samadi M, Daryanoosh F, Mojtahedi Z, Samsamy Pour A, Nobari H, Zarifkar AH, et al. Resistance Training and Resveratrol Supplementation Improve Cancer Cachexia and Tumor Volume in Muscle Tissue of Male Mice Bearing Colon Cancer CT26 Cell Tumors. Cell biochemistry and biophysics. 2025;83(1):619-31.
37. Samare-Najaf M, Kouchaki H, Moein Mahini S, Saberi Rounkian M, Tavakoli Y, Samareh A, et al. Prostate cancer: Novel genetic and immunologic biomarkers. Clinica chimica acta; international journal of clinical chemistry. 2024;555:117824.
38. Shajari N, Baradaran B, Tohidkia MR, Nasiri H, Sepehri M, Setayesh S, et al. Advancements in Melanoma Therapies: From Surgery to Immunotherapy. Current treatment options in oncology. 2024;25(8):1073-88.
39. Shiravani Z, Mirshekari K, Larki MH, Shafiee N, Haghshenas MR, Ghaderi A, et al. Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer. Journal of reproductive immunology. 2024;162:104217.
40. Yazdanpanah-Samani M, Ramezani A, Sheikhi A, Mostafavi-Pour Z, Erfani N. Anti-PD-L1 chimeric antigen receptor natural killer cell: Characterization and functional analysis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2024;132(12):1115-27.
41. Zareinejad M, Faghih Z, Ramezani A, Safaei A, Ghaderi A. Exploring heterogeneous expression of beta-actin (ACTB) in bladder cancer by producing a monoclonal antibody 6D6. BMC urology. 2024;24(1):124.
2023
1. Akrami S, Tahmasebi A, Moghadam A, Ramezani A, Niazi A. Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma. Computers in biology and medicine. 2023;157:106529.
2. Aliabadi A, Haghshenas MR, Kiani R, Koohi-Hosseinabadi O, Purkhosrow A, Pirsalami F, et al. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning. Naunyn-Schmiedeberg's archives of pharmacology. 2024;397(4):2379-88.
3. Alimoradi N, Tahami M, Firouzabadi N, Haem E, Ramezani A. Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA. Arthritis research & therapy. 2023;25(1):35.
4. Arefinia N, Yaghobi R, Ramezani A, Sarvari J. Sequence Analysis of Hot Spot Regions of Spike and RNA-dependent-RNA polymerase (RdRp) Genes of SARS-CoV-2 in Kerman, Iran. Mediterranean journal of hematology and infectious diseases. 2023;15(1):e2023042.
5. Asadi M, Kiani R, Razban V, Faraji SN, Ahmadi A, Fallahi J, et al. Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies. Iranian journal of immunology : IJI. 2023;20(4):410-26.
6. Farahani H, Dehghanian AR, Khademolhosseini A, Haghshenas MR, Erfani N. Frequent expression of CD45RO memory T cell marker as well as low to high expression of PD-1 and PD-L1 inhibitory molecules in seminoma and dysgerminoma. Journal of reproductive immunology. 2024;161:104184.
7. Farjadian F, Faghih Z, Fakhimi M, Iranpour P, Mohammadi-Samani S, Doroudian M. Glucosamine-Modified Mesoporous Silica-Coated Magnetic Nanoparticles: A "Raisin-Cake"-like Structure as an Efficient Theranostic Platform for Targeted Methotrexate Delivery. Pharmaceutics. 2023;15(10).
8. Fattahi MJ, BH AR, Matsuo H, Cuzzocrea S, Jafarnezhad-Ansariha F, Ahmadi H, et al. Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with β-D-mannuronic acid (M2000). The Indian journal of medical research. 2023;157(5):453-9.
9. Gerdabi S, Asadian F, Kiani R, Khademi B, Haghshenas MR, Erfani N. Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment. Head and neck pathology. 2023;17(1):178-92.
10. Ghaderi H, Kruger E, Ahmadvand S, Mohammadi Y, Khademi B, Ghaderi A. Epidemiological Profile of Salivary Gland Tumors in Southern Iranian Population: A Retrospective Study of 405 Cases. Journal of cancer epidemiology. 2023;2023:8844535.
11. Ghoddusi Johari H, Afshari A, Abolhasani Foroughi A, Khademi B, Shahriarirad S, Erfani A, et al. Association of Complications During and After Carotid Body Tumor Resection with Tumor Size and Distance to the Base of Skull. Annals of vascular surgery. 2023;94:223-8.
12. Golchin A, Ranjbarvan P, Parviz S, Shokati A, Naderi R, Rasmi Y, et al. The role of probiotics in tissue engineering and regenerative medicine. Regenerative medicine. 2023;18(8):635-57.
13. Haghshenas MR, Ghaderi H, Daneste H, Ghaderi A. Immunological and biological dissection of normal and tumoral salivary glands. International reviews of immunology. 2023;42(2):139-55.
14. Haghshenas MR, Shiravani Z, Samare-Najaf M, Khansalar S, Razavinasab SA, Ghaderi A, et al. Clinical significance of IL-37 serum level and polymorphism in patients with endometrial cancer. European cytokine network. 2023;34(4):63-9.
15. Hashemi SMA, Moradi A, Hosseini SY, Razavi Nikoo H, Bamdad T, Faghih Z, et al. A New Insight Into p53-Inhibiting Genes in Epstein–Barr Virus-Associated Gastric Adenocarcinoma. Iranian biomedical journal. 2023;27(1):34-45.
16. Hashemi SMA, Moradi A, Hosseini SY, Razavi Nikoo H, Bamdad T, Razmkhah M, et al. EBNA1 Upregulates P53-Inhibiting Genes in Burkitt's Lymphoma Cell Line. Reports of biochemistry & molecular biology. 2023;11(4):672-83.
17. Khademi F, Seghatoleslam A, Ramezani A, Mostafavipour Z, Ghasemi H. Regulation of Epithelial-Mesenchymal Transition by Cyrtopodion Scabrum: An in vitro Study against Colorectal Cancer Cells. Asian Pacific journal of cancer prevention : APJCP. 2023;24(8):2765-72.
18. Khorami Sarvestani S, Shojaeian S, Sarrami-Forooshani R, Yekaninejad MS, Gilany K, Ghaderi A, et al. Cancer Is Associated with the Emergence of Placenta-Reactive Autoantibodies. Biomedicines. 2023;11(2).
19. Kia M, Nekooei F, Alipour AH, Hashemi SMA, Salimi V, Fattahi MJ, et al. Investigation of the Seroprevalence of Antimeasles Immunoglobulin G Antibody in Students at Shiraz University of Medical Sciences. Viral immunology. 2023;36(6):424-8.
20. Maghsoodi N, Zareinejad M, Golestan A, Mahmoudi Maymand E, Ramezani A. Anti-CD19/CD8 bispecific T cell engager for the potential treatment of B cell malignancies. Cellular immunology. 2023;393-394:104787.
21. Molaei V, Fattahi MR, Haghshenas MR, Hosseini SY, Malekhosseini SA, Sarvari J. Polymorphism Analysis of Interleukin-18 and Interleukin-37 Genes in Hepatitis B Infections with Different Outcomes: A Preliminary Report from an Iranian Population. Asian Pacific journal of cancer prevention : APJCP. 2023;24(2):411-6.
22. Ramezani A, Zareinejad M, Mahmoudi Maymand E, Kaviani E, Ghaderi A. Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells. Growth factors (Chur, Switzerland). 2023;41(3):140-51.
23. Roshan Zamir M, Ariafar A, Ghaderi A, Amirzargar A. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer. Immunobiology. 2023;228(2):152319.
24. Sajadian M, Khademi B, Moinzadeh L, Ghaderi A, Jafarzadeh A, Razmkhah M. Modulation of semaphorin 3C & 4D expression in cancerous tissues from individuals with laryngeal squamous cell carcinoma. The Indian journal of medical research. 2023;158(4):432-8.
25. Saleh Z, Mehdipour F, Ataollahi MR, Ali-Hassanzadeh M, Kabelitz D, Kalantar K. Frequency of B-Cell Subpopulations in Low Responders in Comparison with High Responders to Hepatitis B Vaccine Among Health Care Workers. Current microbiology. 2023;80(9):296.
26. Tabaei S, Haghshenas MR, Ariafar A, Gilany K, Stensballe A, Farjadian S, et al. Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity. Clinical proteomics. 2023;20(1):28.
27. Tabaei S, Haghshenas MR, Webster TJ, Ghaderi A. Proteomics strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources. Analytical biochemistry. 2023;666:115074.
28. Tavana S, Mokhtari Z, Sanei MH, Heidari Z, Dehghanian AR, Faghih Z, et al. Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness. Cancer cell international. 2023;23(1):23.
29. Zamani B, Ramazani A, Saberzadeh J, Rostampour P, Takhshid MA. The effect of Annexin A5 overexpression on invasiveness and expression of the genes involved in epithelial-mesenchymal transition of HCT 116 cell line. Molecular biology research communications. 2023;12(2):77-85.
30. Zare S, Emami L, Faghih Z, Zargari F, Faghih Z, Khabnadideh S. Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety. Scientific reports. 2023;13(1):14461.
31. Zareinejad M, Mehdipour F, Roshan-Zamir M, Faghih Z, Ghaderi A. Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis. Cancers. 2023;15(19).
32. Zohouri M, Ghods A, Roshan Zamir M, Shokri F, Ghaderi A. Immune Profiling of SARS-CoV-2; What We Know and What We Don't Know. Iranian journal of allergy, asthma, and immunology. 2023;22(3):217-32.
2022
1. Arefinia N, Ramezani A, Farokhnia M, Arab Zadeh AM, Yaghobi R, Sarvari J. Association between expression of ZBP1, AIM2, and MDA5 genes and severity of COVID-19. EXCLI journal. 2022;21:1171-83.
2. Ariafar A, Sanati A, Ahmadvand S, Shekarkhar G, Safaei A, Shayan Z, et al. Prognostic significance of immunoscore related markers in bladder cancer. BMC urology. 2022;22(1):133.
3. Bagheri Z, Moeinzadeh L, Razmkhah M. Roles of Microbiota in Cancer: From Tumor Development to Treatment. Journal of oncology. 2022;2022:3845104.
4. Balouchi-Anaraki S, Mohammadsadeghi S, Norouzian M, Rasolmali R, Talei AR, Mehdipour F, et al. Expression of Interleukin-21 and Interleukin-21 receptor in lymphocytes derived from tumor-draining lymph nodes of breast cancer. Breast disease. 2022;41(1):373-82.
5. Banakar M, Ardekani ST, Zare R, Malekzadeh M, Mirhadi H, Khademi B, et al. Oral Squamous Cell Carcinoma: The Role of BIRC6 Serum Level. BioMed research international. 2022;2022:5425478.
6. Emami L, Khabnadideh S, Faghih Z, Farahvasi F, Zonobi F, Gheshlaghi SZ, et al. Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents. BMC chemistry. 2022;16(1):100.
7. Fattahi MJ, Haghshenas MR, Ghaderi A. Immunometabolism in the Bladder Cancer Microenvironment. Endocrine, metabolic & immune disorders drug targets. 2022;22(12):1201-16.
8. Fazeli P, Talepoor AG, Faghih Z, Gholijani N, Ataollahi MR, Ali-Hassanzadeh M, et al. The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes. Immunity, inflammation and disease. 2022;10(10):e715.
9. Gerdabi S, Asadian F, Kiani R, Khademi B, Haghshenas MR, Erfani N. Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment. Head and neck pathology. 2023;17(1):178-92.
10. Ghods A, Mehdipour F, Rasolmali R, Talei AR, Ghaderi A. TNF-α is produced by, but not limited to, T helper 1, 2, and 17 in breast tumor-draining lymph nodes. Clinical immunology (Orlando, Fla). 2022;245:109140.
11. Ghods A, Mehdipour F, Rasolmali R, Talei AR, Ghaderi A. The expression pattern of membranous TNF-α is distinct from its intracellular form in breast cancer-draining lymph nodes. Clinical immunology (Orlando, Fla). 2022;238:109026.
12. Haghshenas MR, Erfani N, Khansalar S, Khademi B, Ashraf MJ, Razmkhah M, et al. Proteomics Study of Mesenchymal Stem Cell-Like Cells Obtained from Tumor Microenvironment of Patients with Malignant and Benign Salivary Gland Tumors. Cell journal. 2022;24(4):196-203.
13. Haghshenas MR, Saffarian A, Khademolhosseini A, Dehghanian A, Ghaderi A, Sotoodeh Jahromi A. Simultaneous Increase in Serum Levels of IL-37 and IL-18 Binding Protein In Low-Grade and High-Grade Brain Tumors. Asian Pacific journal of cancer prevention : APJCP. 2022;23(8):2851-6.
14. Haghshenas MR, Zamir MR, Sadeghi M, Fattahi MJ, Mirshekari K, Ghaderi A. Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders. European cytokine network. 2022;33(3):54-69.
15. Heidari F, Ramezani A, Erfani N, Razmkhah M. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases. International reviews of immunology. 2022;41(3):346-63.
16. Hematian Larki M, Ashouri E, Barani S, Ghayumi SMA, Ghaderi A, Rajalingam R. KIR-HLA gene diversities and susceptibility to lung cancer. Scientific reports. 2022;12(1):17237.
17. Jafarzadeh A, Gosain R, Mortazavi SMJ, Nemati M, Jafarzadeh S, Ghaderi A. SARS-CoV-2 Infection: A Possible Risk Factor for Incidence and Recurrence of Cancers. International journal of hematology-oncology and stem cell research. 2022;16(2):117-27.
18. Kangari P, Roshangar L, Iraji A, Talaei-Khozani T, Razmkhah M. Accelerating effect of Shilajit on osteogenic property of adipose-derived mesenchymal stem cells (ASCs). Journal of orthopaedic surgery and research. 2022;17(1):424.
19. Kaviani E, Hosseini A, Mahmoudi Maymand E, Ramzi M, Ghaderi A, Ramezani A. Triggering of lymphocytes by CD28, 4-1BB, and PD-1 checkpoints to enhance the immune response capacities. PloS one. 2022;17(12):e0275777.
20. Maghsood F, Amiri MM, Zarnani AH, Salimi V, Kardar GA, Khoshnoodi J, et al. Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies. Frontiers in medicine. 2022;9:973036.
21. Maghsood F, Shokri MR, Jeddi-Tehrani M, Torabi Rahvar M, Ghaderi A, Salimi V, et al. Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients. Pathogens and disease. 2022;80(1).
22. Mazloomrezaei M, Hosseini MS, Ahmadi N, Mahmoudi Maymand E, Eftekhar E, Asgari A, et al. Introducing a New Method for Purification of Human IL-4 by Substitution of a Single Amino Acid in IL-4 Protein Sequence. Iranian journal of immunology : IJI. 2022;19(4):436-45.
23. Moeinzadeh L, Razeghian-Jahromi I, Zarei-Behjani Z, Bagheri Z, Razmkhah M. Composition, Biogenesis, and Role of Exosomes in Tumor Development. Stem cells international. 2022;2022:8392509.
24. Moghadasi N, Andisheh-Tadbir A, Samiee A, Torabi Ardekani S, Khademi B, Malekzadeh M, et al. Profile of Serum Heat Shock Protein-27 Level in Patients with Salivary Gland Tumor. Journal of dentistry (Shiraz, Iran). 2022;23(3):251-6.
25. Mohammadi Y, Ahmadvand S, Mirtalebi M, Ashraf MJ, Khademi B, Ghaderi A. CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome. Brazilian journal of otorhinolaryngology. 2022;88 Suppl 4(Suppl 4):S133-s42.
26. Namvar N, Montazer M, Ahmadvand S, Sadeghian B, Ghaderi A. Expression of PD-1 in Tumor Cells is Associated with Shorter Survival in Non-metastatic Intestinal-type Gastric Adenocarcinoma. Iranian journal of allergy, asthma, and immunology. 2022;21(6):600-15.
27. Nejabat S, Haghshenas MR, Farjadian S. Allergenome profiling of Vespa orientalis venom by serum IgE in patients with anaphylactic reaction to this hornet sting. Toxicon : official journal of the International Society on Toxinology. 2022;214:130-5.
28. Niknam K, Safaei A, Ghaderi A. Evaluation of the Prognostic Value of CD56 (140 kDa Isoform) Expression in Breast Cancer Tissues: an Eight-Year Retrospective Study. Iranian biomedical journal. 2022;26(3):175-82.
29. Norouzian M, Mehdipour F, Ashraf MJ, Khademi B, Ghaderi A. Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck. BMC immunology. 2022;23(1):56.
30. Razeghian-Jahromi I, Karimi Akhormeh A, Razmkhah M, Zibaeenezhad MJ. Immune system and atherosclerosis: Hostile or friendly relationship. International journal of immunopathology and pharmacology. 2022;36:3946320221092188.
31. Rezaei S, Azarpira N, Koohpeyma F, Yousefi R, Doaei S, Heidari M, et al. Evaluation of morphology and angiogenesis of breast cancer in BALB/c mice using trypsin inhibitor from Cucumis melo seeds. In vitro and in vivo study. Contemporary oncology (Poznan, Poland). 2022;26(3):204-19.
32. Rezayatmand H, Razmkhah M, Razeghian-Jahromi I. Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells. Stem cell research & therapy. 2022;13(1):181.
33. Roshan Zamir M, Ariafar A, Ghaderi A, Amirzargar A. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer. Immunobiology. 2023;228(2):152319.
34. Rostamzadeh D, Haghshenas MR, Samadi M, Mojtahedi Z, Babaloo Z, Ghaderi A. Immunosuppressive Effects and Potent Anti-tumor Efficacy of mTOR Inhibitor Everolimus in Breast Tumor-bearing Mice. Iranian journal of allergy, asthma, and immunology. 2022;21(3):287-99.
35. Salmanpour A, Rezaeifard S, Kiani R, Tahmasebi S, Faghih Z, Erfani N. IFNγ-IL-17-IL-22+CD4+ subset and IL-22-producing cells in tumor draining lymph nodes of patients with breast cancer. Breast disease. 2022;41(1):383-90.
36. Sani M, Hosseinie R, Latifi M, Shadi M, Razmkhah M, Salmannejad M, et al. Engineered artificial articular cartilage made of decellularized extracellular matrix by mechanical and IGF-1 stimulation. Biomaterials advances. 2022;139:213019.
37. Soltan-Alinejad P, Alipour H, Soltani A, Asgari Q, Ramezani A, Mehrabani D, et al. Molecular Characterization and In Silico Analyses of Maurolipin Structure as a Secretory Phospholipase A (2) (sPLA(2)) from Venom Glands of Iranian Scorpio maurus (Arachnida: Scorpionida). Journal of tropical medicine. 2022;2022:1839946.
38. Taeb S, Mosleh-Shiraz MA, Ghaderi A, Mortazavi SMJ, Razmkhah M. Adipose-Derived Mesenchymal Stem Cells Responses to Different Doses of Gamma Radiation. Journal of biomedical physics & engineering. 2022;12(1):35-42.
39. Vakili ME, Faghih Z, Sarvari J, Doroudchi M, Hosseini SN, Kabelitz D, et al. Lower frequency of T stem cell memory (TSCM) cells in hepatitis B vaccine nonresponders. Immunologic research. 2022;70(4):469-80.
40. Zangouri V, Nasrollahi H, Taheri A, Akrami M, Arasteh P, Hamedi SH, et al. Intraoperative radiation therapy for early stage breast cancer. BMC surgery. 2022;22(1):26.
2021
1. Ariafar A, Habibagahi M, Jaberipour M, Khezri A, Hadi Khezri M, Bozorgi H, et al. Upregulation of Cytotoxic T-Lymphocyte-Associated Protein 4 and Forkhead Box P3 Transcripts in Peripheral Blood of Patients with Bladder Cancer. Iranian journal of medical sciences. 2021;46(5):339-46.
2. Ariafar A, Zareinejad M, Soltani M, Vahidi Y, Faghih Z. GM-CSF-producing lymphocytes in tumor-draining lymph nodes of patients with bladder cancer. European cytokine network. 2021;32(1):1-7.
3. Asadi M, Ahmadi N, Ahmadvand S, Jafari AA, Safaei A, Erfani N, et al. Investigation of olfactory receptor family 51 subfamily j member 1 (OR51J1) gene susceptibility as a potential breast cancer-associated biomarker. PloS one. 2021;16(2):e0246752.
4. Asadipour M, Fazeli P, Zohouri M, Bemani P, Mohebbiniya M, Khansalar S, et al. IL-18 in Blood Serum of Hepatitis C Patients Might be of Predictive Value for Individual Outcomes. Infectious disorders drug targets. 2021;21(3):389-93.
5. Ashouri E, Rajalingam K, Barani S, Farjadian S, Ghaderi A, Rajalingam R. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk. Scientific reports. 2021;11(1):7932.
6. Balouchi-Anaraki S, Ahmadvand S, Safaei A, Ghaderi A. 4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application. Iranian biomedical journal. 2021;25(5):310-22.
7. Beizavi Z, Zohouri M, Asadipour M, Ghaderi A. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer. International reviews of immunology. 2021;40(5):319-29.
8. Dorosti H, Nezafat N, Heidari R, Ghoshoon MB, Gholami A, Dehshahri A, et al. Production and Immunological Evaluation of Epitope-based Preventative Pneumococcal Candidate Vaccine Comprising Immunodominant Epitopes from PspA, CbpA, PhtD and PiuA Antigens. Current pharmaceutical biotechnology. 2021;22(14):1900-9.
9. Faghih Z, Taherifard E, Daneshmand A, Talei A, Erfani N. OX40 genetic variations in patients with breast cancer: a case-control study. British journal of biomedical science. 2021;78(1):44-6.
10. Ghahartars M, Abtahi S, Zeinali Z, Fattahi MJ, Ghaderi A. Investigation of TNF-α and IL-6 Levels in the Sera of Non-Melanoma Skin Cancer Patients. Iranian biomedical journal. 2021;25(2):88-92.
11. Ghahartars M, Sedaghat F, Khajavi E, Nejat AA, Malekzadeh M, Ghaderi A, et al. Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer. Dermatology research and practice. 2021;2021:5540163.
12. Ghods A, Ghaderi A, Mehdipour F. Expression of TNFRs by B and T Lymphocytes in Tumor-Draining Lymph Nodes. Methods in molecular biology (Clifton, NJ). 2021;2248:259-69.
13. Ghods A, Mehdipour F, Shariat M, Talei AR, Ghaderi A. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4(+) T cells in the draining lymph nodes of breast cancer. Mol Immunol. 2021;137:52-6.
14. Haghshenas MR, Ghaderi H, Daneste H, Ghaderi A. Immunological and biological dissection of normal and tumoral salivary glands. International reviews of immunology. 2023;42(2):139-55.
15. Haghshenas MR, Hosseini SR, Fattahi MJ, Malekzadeh M, Ariafar A, Ghaderi A. Elevated IL-37 Serum Levels in Patients with Transitional Cell Carcinoma of Bladder. Iranian journal of immunology : IJI. 2021;18(4):346-53.
16. Hashemi S, Jassbi AR, Erfani N, Kiani R, Seradj H. Two new cytotoxic ursane triterpenoids from the aerial parts of Salvia urmiensis Bunge. Fitoterapia. 2021;154:105030.
17. Heidari F, Razmkhah M, Razban V, Erfani N. Effects of indoleamine 2, 3-dioxygenase (IDO) silencing on immunomodulatory function and cancer-promoting characteristic of adipose-derived mesenchymal stem cells (ASCs). Cell biology international. 2021;45(12):2544-56.
18. Maleksabet A, Zarei Jaliani H, Asgari A, Ramezani A, Erfani N. Specific Targeting of Recombinant Human Pancreatic Ribonuclease 1 using Gonadotropin-Releasing Hormone Targeting Peptide toward Gonadotropin-Releasing Hormone Receptor-Positive Cancer Cells. Iranian journal of medical sciences. 2021;46(4):281-90.
19. Nasrollahi H, Khaki S, Ansari M, Ahmadloo N, Khanjani N, Hamedi SH, et al. Evaluation of Mucosamin Effect on Treating Radiation Induced Oral Mucositis during and after Radiotherapy amongst Patients with Oral Cavity Squamous Cell Carcinoma. Asian Pacific journal of cancer prevention : APJCP. 2021;22(11):3711-5.
20. Nazari N, Jafari F, Ghalamfarsa G, Hadinia A, Atapour A, Ahmadi M, et al. The emerging role of microRNA in regulating the mTOR signaling pathway in immune and inflammatory responses. Immunology and cell biology. 2021;99(8):814-32.
21. Pourahmad S, Foroozani S, Nourelahi M, Hosseini A, Razmkhah M. Evaluation of Twenty Genes in Prognosis of Patients with Ovarian Cancer Using Four Different Clustering Methods. Asian Pacific journal of cancer prevention : APJCP. 2021;22(6):1781-7.
22. Ramezani A. CtNorm: Real time PCR cycle of threshold (Ct) normalization algorithm. Journal of microbiological methods. 2021;187:106267.
23. Ramezani A, Asgari A, Kaviani E, Hosseini A, Ghaderi A. Tatibody, a recombinant antibody with higher internalization potency. Mol Immunol. 2021;135:320-8.
24. Razeghian-Jahromi I, Matta AG, Canitrot R, Zibaeenezhad MJ, Razmkhah M, Safari A, et al. Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy. Stem cell research & therapy. 2021;12(1):361.
25. Razeghian-Jahromi I, Zibaeenezhad MJ, Lu Z, Zahra E, Mahboobeh R, Lionetti V. Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure. Heart failure reviews. 2021;26(2):371-80.
26. Rezaeifard S, Heike Y, Masuyama JI, Rezvani A, Vojdani R, Erfani N. Autologous Natural Killer Cell-enrichment for Immune Cell Therapy: Preclinical Setting Phase, Shiraz Experience. Iranian journal of allergy, asthma, and immunology. 2021;20(2):233-43.
27. Rezaeifard S, Talei A, Shariat M, Erfani N. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer. Mol Immunol. 2021;136:161-7.
28. Shadmani A, Razmkhah M, Jalalpoor MH, Lari SY, Eghtedari M. Autologous Activated Omental versus Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Corneal Alkaline Injury: An Experimental Study. Journal of current ophthalmology. 2021;33(2):136-42.
29. Taeb S, Mosleh-Shirazi MA, Ghaderi A, Mortazavi SMJ, Razmkhah M. Radiation-Induced Bystander Effects of Adipose-Derived Mesenchymal Stem Cells. Cell journal. 2021;23(6):612-8.
30. Zareinejad M, Faghih Z, Ariafar A, Safaei A, Ghaderi A. Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers. Human cell. 2021;34(2):675-87.
31. Zohouri M, Mehdipour F, Razmkhah M, Faghih Z, Ghaderi A. CD4(+)CD25(-)FoxP3(+) T cells: a distinct subset or a heterogeneous population? International reviews of immunology. 2021;40(4):307-16.
2020
1. Alicata C., Ashouri E., Nemat-Gorgani N., Guethlein L. A., Marin W. M., et al. KIR Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors. Frontiers in immunology,2020; 11:556
2. Ariafar A., Ghaedi M., Rezaeifard S., Shahriari S., Zeighami S., et al. Clinical relevance and prognostic significance of PD-1/PD-Ls in non-metastatic bladder cancer: A role for PD-L2. Molecular immunology, 2020; 124:35-41
3. Ariafar A., Vahidi Y., Fakhimi M., Asadollahpour A., Erfani N., Faghih Z. Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer. Heliyon, 2020; 6.e05556
4. Asadipour M., Fazeli P., Zohouri M., Bemani P., Mohebbiniya M., et al. IL-18 in Blood Serum of Hepatitis C Patients Might be of Predictive Value for Individual Outcomes. Infectious disorders drug targets2020
5. Barani S., Khademi B., Ghaderi A. KIR2DS4, KIR2DL2, and KIR2DS4del are linked with basaloid tumors, lymph node metastasis, advanced stage and metastatic risk in head and neck squamous cell carcinoma. Experimental and molecular pathology, 2020; 112:104345
6. Barani S., Taghipour M., Ghaderi A. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma. Immunobiology, 2020; 225:151900
7. Beizavi Z., Zohouri M., Asadipour M., Ghaderi A. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer. International reviews of immunology, 2020; 1-11
8. Dehghani Nazhvani A., Sarafraz N., Askari F., Heidari F., Razmkhah M. Anti-Cancer Effects of Traditional Medicinal Herbs on Oral Squamous Cell Carcinoma. Asian Pacific journal of cancer prevention : APJCP, 2020; 21:479-84
9. Fakhimi M., Talei A. R., Ghaderi A., Habibagahi M., Razmkhah M. Helios, CD73 and CD39 Induction in Regulatory T Cells Exposed to Adipose Derived Mesenchymal Stem Cells. Cell journal, 2020; 22:236-44
10. Haghighi A. H., Khorasani M. T., Faghih Z., Farjadian F. Effects of different quantities of antibody conjugated with magnetic nanoparticles on cell separation efficiency. Heliyon,2020; 6.e03677
11. Heidari F., Ramezani A., Erfani N., Razmkhah M. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases. International reviews of immunology, 2020; 1-18
12. Hematian Larki M., Barani S., Talei A. R., Ghaderi A. Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients. Genes and immunity, 2020; 21.380-9
13. Kangari P., Talaei-Khozani T., Razeghian-Jahromi I., Razmkhah M. Mesenchymal stem cells: amazing remedies for bone and cartilage defects. Stem cell research & therapy, 2020; 11.492
14. Karimzadeh P., Faghih Z., Rahmani N., Eghbali F., Razmkhah M. Quantification of angiogenic factors and their clinicopathological associations in breast cancer. European cytokine network, 2020; 31:68-75
15. Shamsdin S. A., Alborzi A., Ghaderi A., Lankrani K. B., Pouladfar G.R. Significance of TC9 and TH9 in Helicobacter pylori-induced gastritis. Helicobacter, 2020; 25.e12672
16. Shariati S., Ghods A., Zohouri M., Rasolmali R., Talei A. R., et al. Significance of TIM-3 expression by CD4(+) and CD8(+) T lymphocytes in tumor-draining lymph nodes from patients with breast cancer. Molecular immunology, 2020; 128:47-54
17. Shariati S., Mehdipour F., Samadi M., Rasolmali R., Talei A. R., Ghaderi A. The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors. Life sciences, 2020; 257:118117
18. Tavangar M. S., Attar A., Razmkhah M., Hosseini S. M., Hosseini A., et al. Differential expression of drug resistance genes in CD146 positive dental pulp derived stem cells and CD146 negative fibroblasts. Clinical and experimental dental research, 2020; 6:448-56
19. Vahidi Y., Bagheri M., Ghaderi A., Faghih Z. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer. BMC cancer, 2020; 20:257
20. Zohouri M., Ghaderi A. The Significance of Biobanking in the Sustainability of Biomedical Research: A Review. Iranian biomedical journal, 2020; 24:206-13
21. Zohouri M., Ghaderi A. Biobank; An Essential Infrastructure for the Future of Personalized Medicine. Archives of Iranian medicine, 2020; 23:59-60
22. Zohouri M., Mehdipour F., Razmkhah M., Faghih Z., Ghaderi A. CD4(+)CD25(-)FoxP3(+) T cells: a distinct subset or a heterogeneous population? International reviews of immunology,2020; 1-10
2019
1. Abtahi S., Hakimrabet S., Malekzadeh M., Deghanian A. R., Ghaderi A. Investigating the Levels of Soluble Extracellular Domain of HER2 Protein in the Sera of Meningioma Patients. Turkish neurosurgery, 2019; 29:9-13
2. Ahmadvand S., Faghih Z., Montazer M., Safaei A., Mokhtari M., et al. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients. Cellular oncology (Dordrecht), 2019; 42:343-56
3. Arabpour M., Rasolmali R., Talei A. R., Mehdipour F., Ghaderi A. Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes. Molecular immunology, 2019; 114:172-8
4. Asgari A., Sharifzadeh S., Ghaderi A., Hosseini A., Ramezani A. In vitro cytotoxic effect of Trastuzumab in combination with Pertuzumab in breast cancer cells is improved by interleukin-2 activated NK cells. Molecular biology reports, 2019; 46:6205-13
5. Barani S., Hosseini S. V., Ghaderi A. Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasis. Immunobiology, 2019; 224:681-6
6. Chatrabnous N., Ghaderi A., Ariafar A., Razeghinia M. S. Nemati M., Jafarzadeh A.,Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer. Cytokine, 2019; 113:221-7
7. Chatrabnous N., Jafarzadeh A., Ghaderi A., Ariafar A. , Aminizadeh N., et al. Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer. European cytokine network, 2019; 30:144-50
8. Faghih Z., Abtahi S., Khademi B., Nikfarjam F., Erfani N. Association of OX40 gene polymorphisms (rs17568G/A and rs229811A/C) with head and neck squamous cell carcinoma. Molecular biology reports, 2019; 46:2609-16
9. Fathi F., Faghih Z., Khademi B., Kayedi T., Erfani N., Gahderi A. PD-1 Haplotype Combinations and Susceptibility of Patients to Squamous Cell Carcinomas of Head and Neck. Immunological investigations, 2019; 48:1-10
10. Ghaderi F., Mehdipour F., Hosseini A., Talei A., Ghaderi A. Establishment and Characterization of a New Triple Negative Breast Cancer Cell Line from an Iranian Breast Cancer Tissue. Asian Pacific journal of cancer prevention : APJCP, 2019; 20:1683-9
11. Ghods A., Ghaderi A., Shariat M., Talei A. R., Mehdipour F. TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes. .Immunology letters, 2019; 209:36-44
12. Jaafari-Ashkvandi Z., Shirazi S. Y., Rezaeifard S., Hamedi A., Erfani N. Cytotoxic Effects of Pistacia Atlantica (Baneh) Fruit Extract on Human KB Cancer Cell Line. Acta medica (Hradec Kralove), 2019; 62:30-4
13. Mansourabadi Z., Razmkhah M., Mohtasebi M. S., Talei A. R., Ghaderi A. Expression of major histocompatibility complex class I polypeptide-related sequence B in adipose-derived stem cells from breast cancer patients and normal individuals. Journal of cancer research and therapeutics, 2019; 15:1067-72
14. Masoud Y., Ramin S., Mahboobeh R., Mehrnoosh M., Fahimeh J., Parastoo K. Effect of Lithium and Valproate on Proliferation and Migration of Limbal Epithelial Stem/Progenitor Cells. Current eye research, 2019; 44:154-61
15. Mehdipour F., Razmkhah M., Faghih Z., Bagheri M., Talei A. R., Ghaderi A. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes. Cellular oncology (Dordrecht), 2019; 42:381-95
16. Niakan A., Faghih Z., Talei A. R., Ghaderi A. Cytokine profile of CD4(+)CD25(-)FoxP3(+) T cells in tumor-draining lymph nodes from patients with breast cancer. Molecular immunology, 2019; 116:90-7
17. Norouzian M., Mehdipour F., Balouchi Anaraki S., Ashraf M. J., Khademi B., Ghaderi A. Atypical Memory and Regulatory B Cell Subsets in Tumor Draining Lymph Nodes of Head and Neck Squamous Cell Carcinoma Correlate with Good Prognostic Factors. Head and neck pathology,2019;
18. Razmkhah M., Abtahi S., Ghaderi A. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment. Current stem cell research & therapy, 2019; 14:43-51
19. Rezaeifard S., Safaei A., Talei A., Faghih Z., Erfani N. NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer. Iranian Journal of Immunology : IJI, 2019; 16:291-8
20. Rostamzadeh D., Haghshenas M. R., Daryanoosh F., Samadi M., Hosseini A., et al. Altered frequency of CD8(+) CD11c(+) T cells and expression of immunosuppressive molecules in lymphoid organs of mouse model of colorectal cancer. Journal of Cellular Physiology, 2019; 234:11986-98
21. Toghraie F. S., Yazdanpanah-Samani M., Mahmoudi Maymand E., Hosseini A., Asgari A., et al. Molecular Cloning, Expression and Purification of G-CSF Isoform D, an Alternative Splice Variant of Human G-CSF. Iranian journal of allergy, asthma, and immunology, 2019; 18:419-26
2018
1. Abtahi S, Asadipour M, Ghaderi A. The Legacy of Mesenchymal Stem Cells in Vindicating the Clonal Evolution Model of Cancer. Asian Pacific journal of cancer prevention : APJCP. 2018;19(8):2029-30.
2. Abtahi S, Izadi Jahromi F, Dabbaghmanesh MH, Malekzadeh M, Ghaderi A. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm. Endocrine. 2018;62(1):159-65.
3. Abtahi S, Malekzadeh M, Nikravan G, Ghaderi A. Measurement of Lung Cancer Tumor Markers in a Glass Wool Company Workers Exposed to Respirable Synthetic Vitreous Fiber and Dust. The international journal of occupational and environmental medicine. 2018;9(1):23-31.
4. Alireza Bolourian AS, Mojtahedi Z. Blocking natural killer cells in testicular torsion may prevent autoimmunity against low expressing major histocompatibility complex class I germ cells. The Indian journal of medical research. 2018;147(2):128-31.
5. Barani S, Khademi B, Ashouri E, Ghaderi A. KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians. Human immunology. 2018;79(4):218-23. Epub 2018/02/07.
6. Bolourian A, Mojtahedi Z. Streptomyces, shared microbiome member of soil and gut, as 'old friends' against colon cancer. FEMS microbiology ecology. 2018;94(8).
7. Bolourian A, Mojtahedi Z. Immunosuppressants produced by Streptomyces: evolution, hygiene hypothesis, tumour rapalog resistance and probiotics. Environmental microbiology reports. 2018;10(2):123-6.
8. Faghih Z, Deihimi S, Talei A, Ghaderi A, Erfani N. Analysis of T cell receptor repertoire based on Vbeta chain in patients with breast cancer. Cancer biomarkers : section A of Disease markers. 2018;22(4):733-45.
9. Ghaderi A, Abtahi S. Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers? Stem cell reviews. 2018;14(5):722-33.
10. Ghaderi F, Ahmadvand S, Ramezani A, Montazer M, Ghaderi A. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line. Biochemical and biophysical research communications. 2018;505(1):181-6.
11. Ghaderi H, Razmkhah M, Kiany F, Chenari N, Haghshenas MR, Ghaderi A. Comparison of Osteogenic and Chondrogenic Differentiation Ability of Buccal Fat Pad Derived Mesenchymal Stem Cells and Gingival Derived Cells. Journal of dentistry (Shiraz, Iran). 2018;19(2):124-31.
12. Jamali E, Barani S, Yousefinejad F, Ariafar A, Talei GR, Ghaderi A. KIRs gene content diversity in Iranians with urothelial bladder cancer. Molecular biology reports. 2018;45(5):713-9.
13. Kavousipour S, Mokarram P, Gargari SLM, Mostafavi-Pour Z, Barazesh M, Ramezani A, et al. A Comparison Between Cell, Protein and Peptide-Based Approaches for Selection of Nanobodies Against CD44 from a Synthetic Library. Protein and peptide letters. 2018;25(6):580-8.
14. Lavaee F, Zare S, Mojtahedi Z, Malekzadeh M, Khademi B, Ghaderi A. Serum CXCL12, but not CXCR4, Is Associated with Head and Neck Squamous Cell Carcinomas. Asian Pacific journal of cancer prevention : APJCP. 2018;19(4):901-4.
15. Mehdipour F, Razmkhah M, Rezaeifard S, Bagheri M, Talei AR, Khalatbari B, et al. Mesenchymal stem cells induced anti-inflammatory features in B cells from breast tumor draining lymph nodes. Cell biology international. 2018.
16. Negahdaripour M, Nezafat N, Eslami M, Ghoshoon MB, Shoolian E, Najafipour S, et al. Structural vaccinology considerations for in silico designing of a multi-epitope vaccine. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2018;58:96-109.
17. Ramezani A, Ghaderi A. Using a Dihydrofolate Reductase-Based Strategy for Producing the Biosimilar Version of Pertuzumab in CHO-S Cells. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2018;37(1):26-37.
18. Razmkhah M, Abtahi S, Ghaderi A. Mesenchymal stem cells, immune cells and tumor cells cross talk: A sinister triangle in the tumor microenvironment. Current stem cell research & therapy. 2018.
19. Razmkhah M, Mansourabadi Z, Mohtasebi MS, Talei AR, Ghaderi A. Cancer and normal adipose-derived mesenchymal stem cells (ASCs): Do they have differential effects on tumor and immune cells? Cell biology international. 2018;42(3):334-43.
20. Rezaei M, Nikeghbalian S, Mojtahedi Z, Ghaderi A. Identification of antibody reactive proteins in pancreatic cancer using 2D immunoblotting and mass spectrometry. Oncology reports. 2018;39(5):2413-21.
21. Shaaban Z, Jafarzadeh Shirazi MR, Nooranizadeh MH, Tamadon A, Rahmanifar F, Ahmadloo S, et al. Decreased Expression of Arginine-Phenylalanine-Amide-Related Peptide-3 Gene in Dorsomedial Hypothalamic Nucleus of Constant Light Exposure Model of Polycystic Ovarian Syndrome. International journal of fertility & sterility. 2018;12(1):43-50.
22. Vahidi Y, Faghih Z, Talei AR, Doroudchi M, Ghaderi A. Memory CD4(+) T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells. Cellular oncology (Dordrecht). 2018;41(1):1-11.
23. Vakili B, Eslami M, Hatam GR, Zare B, Erfani N, Nezafat N, et al. Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum. International journal of biological macromolecules. 2018;120(Pt A):1127-39.
24. Vakili B, Nezafat N, Hatam GR, Zare B, Erfani N, Ghasemi Y. Proteome-scale identification of Leishmania infantum for novel vaccine candidates: A hierarchical subtractive approach. Computational biology and chemistry. 2018;72:16-25.
25. Zargar P, Ghani E, Mashayekhi FJ, Ramezani A, Eftekhar E. Acriflavine enhances the antitumor activity of the chemotherapeutic drug 5-fluorouracil in colorectal cancer cells. Oncology letters. 2018;15(6):10084-90.
2017
1. Abtahi S, Davani F, Mojtahedi Z, Hosseini SV, Bananzadeh A, Ghaderi A. Dual association of serum interleukin-10 levels with colorectal cancer. Journal of cancer research and therapeutics. 2017;13(2):252-6.
2. Abtahi S, Hakimrabet S, Malekzadeh M, Deghanian AR, Ghaderi A. Investigating the levels of soluble extracellular domain of HER2 protein in the sera of meningioma patients. Turkish neurosurgery. 2017.
3. Bahrami B, Hosseini A, Talei AR, Ghaderi A, Razmkhah M. Adipose Derived Stem Cells Exert Immunomodulatory Effects on Natural Killer Cells in Breast Cancer. Cell journal. 2017;19(1):137-45.
4. Bamdad S, Khademi B, Chenari N, Taseh A, Razmkhah M. Stromal cell derived factor-1, CXCR4 and CXCR7 gene transcripts in pterygia. Journal of current ophthalmology. 2017;29(1):28-32.
5. Bolourian A, Mojtahedi Z. Possible damage to immune-privileged sites in natural killer cell therapy in cancer patients: side effects of natural killer cell therapy. Immunotherapy. 2017;9(3):281-8.
6. Dowran R, Sarvari J, Moattari A, Fattahi MR, Ramezani A, Hosseini SY. Analysis of TLR7, SOCS1 and ISG15 immune genes expression in the peripheral blood of responder and non-responder patients with chronic Hepatitis C. Gastroenterology and hepatology from bed to bench. 2017;10(4):272-7.
7. Esmailbeig M, Ghaderi A. Interleukin-18: a regulator of cancer and autoimmune diseases. European cytokine network. 2017;28(4):127-40.
8. Faghihi SA, Khankeh HR, Hosseini SJ, Soltani Arabshahi SK, Faghih Z, Shirazi M. Impractical CME programs: Influential parameters in Iran. Medical journal of the Islamic Republic of Iran. 2017;31:6.
9. Fereidoonnezhad M, Niazi M, Shahmohammadi Beni M, Mohammadi S, Faghih Z, Faghih Z, et al. Synthesis, Biological Evaluation, and Molecular Docking Studies on the DNA Binding Interactions of Platinum(II) Rollover Complexes Containing Phosphorus Donor Ligands. ChemMedChem. 2017;12(6):456-65.
10. Ghalamfarsa G, Hosseini SV, Hamidinia M, Ghaderi A, Mahmoudi M, Mojtahedi Z. Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera. Advanced biomedical research. 2017;6:6.
11. Golestan A, Ghaderi A, Mojtahedi Z. Effects of NDRG2 Overexpression on Metastatic Behaviors of HCT116 Colorectal Cancer Cell Line. Advanced pharmaceutical bulletin. 2017;7(4):661-4.
12. Haghshenas MR, Ashraf MJ, Khademi B, Ghaderi A, Erfani N, Razmkhah M. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7. European cytokine network. 2017;28(1):27-35.
13. Haghshenas MR, Dabbaghmanesh MH, Miri A, Ghaderi A, Erfani N. Association of PDCD1 gene markers with susceptibility to thyroid cancer. Journal of endocrinological investigation. 2017;40(5):481-6.
14. Khaghanzadeh N, Samiei A, Mojtahedi Z, Ramezani M, Hosseinzadeh M, Ghaderi A. Umbelliprenin induced both anti-inflammatory and regulatory cytokines in C57/BL6 mice. Iranian journal of basic medical sciences. 2017;20(7):829-34.
15. Malek-Hosseini Z, Jelodar S, Talei A, Ghaderi A, Doroudchi M. Elevated Syndecan-1 levels in the sera of patients with breast cancer correlate with tumor size. Breast cancer (Tokyo, Japan). 2017;24(6):742-7.
16. Menezes J, Edraki N, Kamat SP, Khoshneviszadeh M, Kayani Z, Mirzaei HH, et al. Long Chain Alkyl Esters of Hydroxycinnamic Acids as Promising Anticancer Agents: Selective Induction of Apoptosis in Cancer Cells. Journal of agricultural and food chemistry. 2017;65(33):7228-39.
17. Namavar Jahromi F, Samadi M, Mojtahedi Z, Haghshenas MR, Taghipour M, Erfani N. Association of PD-1.5 C/T, but Not PD-1.3 G/A, with Malignant and Benign Brain Tumors in Iranian Patients. Immunological investigations. 2017;46(5):469-80.
18. Negahdaripour M, Eslami M, Nezafat N, Hajighahramani N, Ghoshoon MB, Shoolian E, et al. A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2017;54:402-16.
19. Ramezani A, Mahmoudi Maymand E, Yazdanpanah-Samani M, Hosseini A, Toghraie FS, Ghaderi A. Improving Pertuzumab production by gene optimization and proper signal peptide selection. Protein expression and purification. 2017;135:24-32.
20. Rezaei M, Ghaderi A. Production of a Mouse Monoclonal Antibody Against Mortalin by Whole Cell Immunization. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017;36(4):169-75.
21. Rezaei M, Hosseini A, Nikeghbalian S, Ghaderi A. Establishment and characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from pancreas. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al]. 2017;17(2):303-9.
22. Shahriari S, Rezaeifard S, Moghimi HR, Khorramizadeh MR, Faghih Z. Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines. Cancer biomarkers : section A of Disease markers. 2017;18(4):375-80.
23. Shamsdin SA, Alborzi A, Rasouli M, Ghaderi A, Lankrani KB, Dehghani SM, et al. The importance of TH22 and TC22 cells in the pathogenesis of Helicobacter pylori-associated gastric diseases. Helicobacter. 2017;22(3).
24. Taghipour M, Omidvar A, Razmkhah M, Ghaderi A, Mojtahedi Z. Comparative Proteomic Analysis of Tumor Mesenchymal-Like Stem Cells Derived from High Grade versus Low Grade Gliomas. Cell journal. 2017;19(2):250-8.
25. Toghraie FS, Sharifzadeh SM, Ramezani A, Mahmoudi Maymand E, Yazdanpanah-Samani M, Ghaderi A. Cloning and Expression of Recombinant Human Interleukin-7 in Chinese Hamster Ovary (CHO) Cells. Reports of biochemistry & molecular biology. 2017;6(1):66-73.
2016
1. Ashouri E, Norman PJ, Guethlein LA, Han AS, Nemat-Gorgani N, Norberg SJ, et al. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands. Hla. 2016;88(3):87-99.
2. Ayatollahi M, Talaei-Khozani T, Razmkhah M. Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton's jelly of umbilical cord on PBMCs. Iranian journal of basic medical sciences. 2016;19(2):145-53.
3. Bahramali E, Firouzabadi N, Yavarian I, Shayesteh MR, Erfani N, Shoushtari AA, et al. Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial. European journal of clinical pharmacology. 2016;72(9):1059-64.
4. Bolourian A, Mojtahedi Z. Monitoring of CD8(+) T-cell Activity in mTOR Inhibitor-treated Cancer Patients for Successful Immunotherapy. Archives of medical research. 2016;47(5):401-2.
5. Faghihi SA, Khankeh HR, Hosseini SJ, Soltani Arabshahi SK, Faghih Z, Parikh SV, et al. Improving continuing medical education by enhancing interactivity: lessons from Iran. Journal of advances in medical education & professionalism. 2016;4(2):54-63.
6. Faraji A, Abtahi S, Ghaderi A, Samsami Dehaghani A. Transforming Growth Factor beta1 (TGF-beta1) in the Sera of Postmenopausal Osteoporotic Females. International journal of endocrinology and metabolism. 2016;14(4):e36511.
7. Fazel Anvari-Yazdi A, Tahermanesh K, Hadavi SM, Talaei-Khozani T, Razmkhah M, Abed SM, et al. Cytotoxicity assessment of adipose-derived mesenchymal stem cells on synthesized biodegradable Mg-Zn-Ca alloys. Materials science & engineering C, Materials for biological applications. 2016;69:584-97.
8. Firouzabadi N, Ghazanfari N, Alavi Shoushtari A, Erfani N, Fathi F, Bazrafkan M, et al. Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study. PloS one. 2016;11(4):e0153667.
9. Haghshenas MR, Khademi B, Ashraf MJ, Ghaderi A, Erfani N. Helper and cytotoxic T-cell subsets (Th1, Th2, Tc1, and Tc2) in benign and malignant salivary gland tumors. Oral diseases. 2016;22(6):566-72.
10. Jafarinia M, Mehdipour F, Hosseini SV, Ghahramani L, Hosseinzadeh M, Ghaderi A. Determination of a CD4(+)CD25(-)FoxP3(+) T cells subset in tumor-draining lymph nodes of colorectal cancer secreting IL-2 and IFN-gamma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(11):14659-66.
11. Jafarzadeh A, Fooladseresht H, Nemati M, Assadollahi Z, Sheikhi A, Ghaderi A. Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism. Cancer biomarkers : section A of Disease markers. 2016;16(4):545-54.
12. Khaghanzadeh N, Nakamura K, Kuramitsu Y, Ghaderi A, Mojtahedi Z. Immune-associated proteins with potential in vivo anti-tumor activities are upregulated in lung cancer cells treated with umbelliprenin: A proteomic approach. Oncology letters. 2016;12(6):5295-302.
13. Mehdipour F, Razmkhah M, Hosseini A, Bagheri M, Safaei A, Talei AR, et al. Increased B Regulatory Phenotype in Non-Metastatic Lymph Nodes of Node-Positive Breast Cancer Patients. Scandinavian journal of immunology. 2016;83(3):195-202.
14. Shahsavani MB, Ahmadi S, Aseman MD, Nabavizadeh SM, Rashidi M, Asadi Z, et al. Anticancer activity assessment of two novel binuclear platinum (II) complexes. Journal of photochemistry and photobiology B, Biology. 2016;161:345-54.
15. Shegefti MS, Malekzadeh M, Malek-Hosseini Z, Khademi B, Ghaderi A, Doroudchi M. Reduced serum levels of syndecan-1 in patients with tongue squamous cell carcinoma. The Laryngoscope. 2016;126(5):E191-5.
17. Tati K, Yazdanpanah-Samani M, Ramezani A, Mahmoudi Maymand E, Ghaderi A. Establishment a CHO Cell Line Expressing Human CD52 Molecule. Reports of biochemistry & molecular biology. 2016;5(1):56-61.
18. Yadegari ZS, Akrami H, Hosseini SV, Erfani N. miR-146a gene polymorphism and susceptibility to gastric cancer. British journal of biomedical science. 2016;73(4):201-3.
19. Yazdani Y, Sharifi Rad MR, Taghipour M, Chenari N, Ghaderi A, Razmkhah M. Genistein Suppression of Matrix Metalloproteinase 2 (MMP-2) and Vascular Endothelial Growth Factor (VEGF) Expression in Mesenchymal Stem Cell Like Cells Isolated from High and Low Grade Gliomas. Asian Pacific journal of cancer prevention : APJCP. 2016;17(12):5303-7.
2015
1. Sanaee MN, Malekzadeh M, Khezri A, Ghaderi A, Doroudchi M. Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer. Urologia internationalis. 2015;94(4):472-8.
2. Rezaeifard S, Razmkhah M, Robati M, Momtahan M, Ghaderi A. Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancer. Iranian journal of medical sciences. 2015;40(3):225-32.
3. Razmkhah M, Abedi N, Hosseini A, Imani MT, Talei AR, Ghaderi A. Induction of T Regulatory Subsets from Naive CD4+ T Cells after Exposure to Breast Cancer Adipose Derived Stem Cells. Iranian journal of immunology : IJI. 2015;12(1):1-15.
4. Nemati K, Golmoghaddam H, Hosseini SV, Ghaderi A, Doroudchi M. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression. Gene. 2015;561(1):88-94.
5. Namazi S, Sahebi E, Rostami-Yalmeh J, Jaberipour M, Razmkhah M, Hosseini A, et al. Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36(2):893-900.
6. Rezaeifard S, Razmkhah M, Robati M, et al. Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancer. Iranian journal of medical sciences. 2015;40(3):225-232.
7. Razmkhah M, Abedi N, Hosseini A, et al. Induction of T Regulatory Subsets from Naive CD4+ T Cells after Exposure to Breast Cancer Adipose Derived Stem Cells. Iranian journal of immunology : IJI. 2015;12(1):1-15.
8. Omidvari S, Zohourinia S, Ansari M, et al. Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Annals of coloproctology. 2015;31(4):123-130.
9. Nemati K, Golmoghaddam H, Hosseini SV, et al. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression. Gene. 2015;561(1):88-94.
10. Khosravi-Maharlooei M, Jaberipour M, Hosseini Tashnizi A, et al. Expression Pattern of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase (hTERT) in Cancer Cell Lines Was not Associated with the Origin of the Cells. International journal of molecular and cellular medicine. 2015;4(2):109-119.
11. Khodadad M, Hosseini SY, Shenavar F, et al. Construction of expressing vectors including melanoma differentiation-associated gene-7 (mda-7) fused with the RGD sequences for better tumor targeting. Iranian journal of basic medical sciences. 2015;18(8):780-787.
12. Haghshenas MR, Khademi B, Faghih Z, et al. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors. Immunology letters. 2015;164(2):109-116.
13. Golestan AM, Mojtahedi ZP, Ghalamfarsa GP, et al. The Effects of NDRG2 Overexpression on Cell Proliferation and Invasiveness of SW48 Colorectal Cancer Cell Line. Iranian journal of medical sciences. 2015;40(5):430-439.
14. Fazelzadeh Haghighi M, Ali Ghayumi M, Behzadnia F, et al. Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma. Iranian journal of basic medical sciences. 2015;18(5):465-471.
15. Faraji SN, Mojtahedi Z, Ghalamfarsa G, et al. N-myc downstream regulated gene 2 overexpression reduces matrix metalloproteinase-2 and -9 activities and cell invasion of A549 lung cancer cell line in vitro. Iranian journal of basic medical sciences. 2015;18(8):773-779.
16. Erfani N, Nazemosadat Z, Moein M. Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D. Pharmacognosy research. 2015;7(2):133-137.
17. Baharlou R, Khezri A, Razmkhah M, et al. Increased interleukin-17 transcripts in peripheral blood mononuclear cells, a link between T-helper 17 and proinflammatory responses in bladder cancer. Iranian Red Crescent medical journal. 2015;17(2):e9244.
